The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China. The company disclosed preliminary results in mid January, but it left out important ...
Highlights,Hillenbrand's Q1 revenue of $707 million decreased 9% year-over-year, in line with expectations.,The company is ...
Hosted on MSN20m
Bain Capital Nears Acquisition of Mitsubishi’s Pharma Division in $3.2 Billion DealDubai Bain Capital is in the final stages of negotiations to acquire Mitsubishi Chemical Group’s pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, for over 500 billion yen . This move aligns with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback